Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?

Full text
Author(s):
Garcia, Natalia [1] ; Bozzini, Nilo [1] ; Baiocchi, Glauco [2] ; da Cunha, Isabela Werneck [2] ; Maciel, Gustavo Arantes [1] ; Soares Junior, Jose Maria [1] ; Soares, Fernando Augusto [2] ; Baracat, Edmund Chada [1] ; Carvalho, Katia Candido [1]
Total Authors: 9
Affiliation:
[1] Univ Sao Paulo, Hosp Clin, Lab Mol & Struct Gynecol, Disciplina Ginecol, Fac Med, BR-01245903 Sao Paulo - Brazil
[2] Hosp AC Camargo Canc Ctr, Int Res Ctr, CIPE, BR-01509010 Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: HUMAN PATHOLOGY; v. 50, p. 43-50, APR 2016.
Web of Science Citations: 3
Abstract

Several studies have demonstrated that the Sonic Hedgehog signaling pathway (SHH) plays an important role in tumorigenesis and cellular differentiation. We analyzed the protein expression of SHH pathway components and evaluated whether their profile could be useful for the diagnosis, prognosis, or prediction of the risk of malignancy for uterine smooth muscle tumors (USMTs). A total of 176 samples (20 myometrium, 119 variants of leiomyoma, and 37 leiomyosarcoma) were evaluated for the protein expression of the SHH signaling components, HHIP1 (SHH inhibitor), and BMP4 (SHE target) by immunohistochemistry. Western blot analysis was performed to verify the specificity of the antibodies. We grouped leiomyoma samples into conventional leiomyomas and unusual leiomyomas that comprise atypical, cellular, mitotically active leiomyomas and uterine smooth muscle tumors of uncertain malignant potential. Immunohistochemical analysis showed that SMO, SUFU, GLIL GLI3, and BMP4 expression gradually increased depending on to the histologic tissue type. The protein expression of SMO, SUFU, and GLI1 was increased in unusual leiomyoma and leiomyosarcoma samples compared to normal myometrium. The inhibitor HHIP1 showed higher expression in myometrium, whereas only negative or basal expression of SMO, SUFU, GLIL and GLI3 was detected in these samples. Strong expression of SHE was associated with poorer overall survival. Our data suggest that the expression of SHH proteins can be useful for evaluating the potential risk of malignancy for USMTs. Moreover, GLI1 and SMO may serve as future therapeutic targets for women with USMTs. (C) 2015 Elsevier Inc. All rights reserved. (AU)

FAPESP's process: 12/10098-5 - Sonic Hedgehog signaling pathway in uterine leiomyoma and leiomyosarcoma: Protein and transcriptional expression study and evaluation of the gene methylation profile
Grantee:Kátia Cândido Carvalho
Support Opportunities: Regular Research Grants